FDA warns of stolen batches of Novo Nordisk's Levemir insulin

06/15/2009 | United Press International · Bloomberg

Novo Nordisk and the FDA warned that nearly 130,000 vials of long-acting Levemir insulin were stolen and could have been mishandled, making them potentially dangerous for patients. The agency said it received one report of adverse events linked to the stolen lots, identified as XZF0036, XZF0037 and XZF0038.

View Full Article in:

United Press International · Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO